These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3609757

  • 1. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.
    Lund-Andersen H, Larsen M, Dalgaard P, Olsen W.
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):173-6. PubMed ID: 3609757
    [Abstract] [Full Text] [Related]

  • 2. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.
    Blair NP, Evans MA, Lesar TS, Zeimer RC.
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1107-14. PubMed ID: 3721789
    [Abstract] [Full Text] [Related]

  • 3. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE, Chahal PS, Fallon TJ, Cunningham JR, Neal MJ, Kohner EM.
    Exp Eye Res; 1987 Feb; 44(2):209-15. PubMed ID: 3582508
    [Abstract] [Full Text] [Related]

  • 4. Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.
    Blair NP, Evans MA, Lesar TS, Willett M.
    Graefes Arch Clin Exp Ophthalmol; 1989 Feb; 227(2):114-7. PubMed ID: 2721978
    [Abstract] [Full Text] [Related]

  • 5. Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous flyorophotometry.
    Takahashi J, Mori F, Hikichi T, Yoshida A.
    Curr Eye Res; 2001 Sep; 23(3):166-70. PubMed ID: 11803477
    [Abstract] [Full Text] [Related]

  • 6. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB, Sander B, Larsen M, Dalgaard P, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [Abstract] [Full Text] [Related]

  • 7. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
    Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calculation of the permeability of the blood-retinal barrier to fluorescein.
    Lund-Andersen H, Krogsaa B, Larsen J.
    Graefes Arch Clin Exp Ophthalmol; 1985 Dec; 222(4-5):173-6. PubMed ID: 3979839
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blood-ocular barrier permeability in monkeys.
    Yoshida A, Ishiko S, Kojima M, Lipsky SN.
    Br J Ophthalmol; 1992 Feb; 76(2):84-7. PubMed ID: 1739721
    [Abstract] [Full Text] [Related]

  • 14. Experimental retinal detachment. VI. The permeability of the blood-retinal barrier.
    Cantrill HL, Pederson JE.
    Arch Ophthalmol; 1984 May; 102(5):747-51. PubMed ID: 6721768
    [Abstract] [Full Text] [Related]

  • 15. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways.
    Araie M, Maurice DM.
    Exp Eye Res; 1991 Jan; 52(1):27-39. PubMed ID: 1714398
    [Abstract] [Full Text] [Related]

  • 16. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP, Rusin MM.
    Graefes Arch Clin Exp Ophthalmol; 1986 Jan; 224(5):419-22. PubMed ID: 3093315
    [Abstract] [Full Text] [Related]

  • 17. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M, Dalgaard P, Lund-Andersen H.
    Graefes Arch Clin Exp Ophthalmol; 1991 Jan; 229(4):350-7. PubMed ID: 1916323
    [Abstract] [Full Text] [Related]

  • 18. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H, Krogsaa B, la Cour M, Larsen J.
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [Abstract] [Full Text] [Related]

  • 19. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M.
    Acta Ophthalmol Suppl (1985); 1993 May; (211):1-52. PubMed ID: 8318868
    [Abstract] [Full Text] [Related]

  • 20. Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein.
    Larsen M, Loft S, Hommel E, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):427-32. PubMed ID: 3195322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.